Thomas J. Webster is a world-renowned biomedical engineer and entrepreneur with over 28 years of experience at the forefront of nanotechnology and biomaterials science. He currently holds professorships at Hebei University of Technology, Saveetha University, Vellore Institute of Technology, UFPI, and Brown University, demonstrating his global academic influence. Webster earned his BSc in Chemical Engineering from the University of Pittsburgh and his PhD in Biomedical Engineering from Rensselaer Polytechnic Institute, the oldest engineering school in the United States. His distinguished academic career includes professorships at Purdue University from 2000 to 2005, Brown University from 2005 to 2012, and Northeastern University from 2012 to 2021, where he served as Chemical Engineering Department Chair and led significant departmental initiatives.
Webster's pioneering research has focused on developing nano-optimized science and the application of nanotechnology to solve critical healthcare challenges through innovative biomaterials. His extensive scholarly output comprises over 1,350 publications with an impressive H-index of 129, reflecting substantial impact across multiple scientific disciplines. Webster and his research team have developed nanotextured implants now used in over 30,000 patients with remarkable clinical outcomes, demonstrating no cancer, no infection, and no failure. His technological innovations have led to numerous FDA-approved medical products that are currently improving human health worldwide, with applications extending to sustainability and renewable energy solutions through novel polymer functionalization strategies.
As a former President of the U.S. Society for Biomaterials, Webster has significantly shaped the direction of biomaterials research and development globally through professional leadership and community building. His entrepreneurial spirit has led to the formation of over a dozen companies dedicated to translating scientific discoveries into practical healthcare solutions with tangible patient impact. Webster has received numerous prestigious honors including recognition as a World Top 2% Scientist by Citations, SCOPUS Highly Cited Researcher in the top 1% of Materials Science, and the Clarivate Top 0.1% Most Influential Researchers in Pharmacology and Toxicology. Recently nominated for the Nobel Prize in Chemistry, Webster continues to advance biomedical innovation while supporting future generations through initiatives like his fund for Nigerian student research opportunities in the United States.
